Ilona Steigerwald - Concepedia

Author

Ilona Steigerwald

Grünenthal Group (Germany)

Also Known As

I. Steigerwald, Ilona Steigerwald, Ilona Steigerwald, MD, PhD, Steigerwald, I.

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Grünenthal Group (Germany)University Hospital Schleswig-Holstein University of Lübeck Gartnavel General Hospital Zimmer Biomet (Germany)

About

Ilona Steigerwald is an author at Grünenthal Group (Germany) specializing in pain medicine, medicine, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	392
2	Health Sciences	2	2	312
3	Anesthesia	1	1	80
4	Diabetes	1	1	80
5	Neurology	1	1	80

Ilona Steigerwald

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin, Dennis C. Turk, Sarah Peirce‐Sandner, Pain Pain TherapyPain MedicinePharmacotherapyPain SyndromeClinical Trials	2012	276
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study Ralf Baron, V. Mayoral, Göran Leijon, Current Medical Research and Opinion	2009	187
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations Shannon M. Smith, Robert H. Dworkin, Dennis C. Turk, Pain	2020	156
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy Ralf Baron, V. Mayoral, Göran Leijon, Current Medical Research and Opinion	2009	104
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study Ilona Steigerwald, Matthias Müller, Anthony Davies, Current Medical Research and Opinion	2012	82
Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy Ralf Baron, V. Mayoral, Göran Leijon, Clinical Drug Investigation Pain MedicineDiabetesPostherpetic NeuralgiaDiabetic NeuropathyNeuropathic Pain	2009	80
Effectiveness of Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐Label, Phase 3b/4 Study Ralf Baron, Rudolf Likar, E. Martín‐Mola, Pain Practice	2015	68
Effectiveness and Safety of Tapentadol Prolonged Release (<scp>PR</scp>) Versus a Combination of Tapentadol <scp>PR</scp> and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study Ralf Baron, E. Martín‐Mola, Matthias Müller, Pain Practice	2014	68
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial Ralf Baron, Jan‐Peter Jansen, Andreas Binder, Pain Practice	2015	67
Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain Ilona Steigerwald, Michael Schenk, Uwe Lahne, Clinical Drug Investigation	2013	47

Page 1